TD2 to Present at the Upcoming 4th Annual Tumor Models in Boston

July 15, 2016

TD2’s VP of Nonclinical Operations, Paul Gonzales, will be presenting at the upcoming 4th Annual Tumor Models – Boston (www.tumor-models.com) on Wednesday, July 20th. The topic of the presentation is The Role of the Gut Microbiome on the Anti-Tumor Response of Immune Checkpoint Inhibitors in a Syngeneic Murine Model of HPV-Associated Cancer.

Specimen Stability Considerations During Flow Cytometry Assay Development, Optimization and Validation
Fluorescent Cell Barcoding Using Flow Cytometry For High Throughput Testing
Flow Cytometry Processing and Analysis of Tumor Specimens: Testing Viability and Staining Post Shipping
The Importance of Conducting PDX Oncology Studies in a Humanized Immune System
Leveraging Flow Cytometry to Drive Better Patient Outcomes in Hematologic Malignancy Clinical Trials

Specimen Stability Considerations During Flow Cytometry Assay Development, Optimization and Validation

By Jennifer J. Stewart, PhD

Fluorescent Cell Barcoding Using Flow Cytometry For High Throughput Testing

By Rubina Pal, PhD, Flow Cytometry Scientist

Flow Cytometry Processing and Analysis of Tumor Specimens: Testing Viability and Staining Post Shipping

By Hillary Reif, Administrative Assistant/Research Associate I and Christine Samuelson, Administrative Assistant

Get Started

Contact Us Today!

If you’re looking for an expert team to guide your trial with efficiency in mind, we can help. As the creators of the Dynamic Trial, TD2 provides start-to-finish support with trial strategy, design and execution for faster go-to-market potential.

Get Started Now